Genetics of infectious diseases

Human Molecular Genetics

Volumn 13, Issue REV. ISS. 2, 2004, Pages

  Frodsham, Angela J ^a   Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; ENVIRONMENTAL FACTOR; FAMILY STUDY; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFECTION SENSITIVITY; MALARIA; MICROORGANISM; MORTALITY; MYCOBACTERIOSIS; NONHUMAN; PARASITOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SAMPLE SIZE; VIRUS INFECTION;

ANIMALS; COMMUNICABLE DISEASES; HUMANS;

BACTERIA (MICROORGANISMS);

EID: 5444251622     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh225     Document Type: Review

References (136)

1. Haldane, J.B.S. (1949) Disease and evolution. Ricercha Sci. 19 (suppl.), 68-76.
2. Sorensen, T.I., Nielsen, G.G., Andersen, P.K. and Teasdale, T.W. (1988) Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med., 318, 727-732.
3. Chakravarti, M.R. and Vogel, F. (1973) A twin study in leprosy. Top. Hum. Genet., 1, 1-123.
4. Comstock, G.W. (1978) Tuberculosis in twins: a re-analysis of the Prophit survey. Am. Rev. Respir. Dis., 117, 621-624.
5. Jepson, A.P., Banya, W.A., Sisay-Joof, F., Hassan-King, M., Bennett, S. and Whittle, H.C. (1995) Genetic regulation of fever in Plasmodium falciparum malaria in Gambian twin children. J. Infect. Dis., 172, 316-319.
6. Lin, T.M., Chen, C.J., Wu, M.M., Yang, C.S., Chen, J.S., Lin, C,C., Kwang, T.Y., Hsu, S.T., Lin, S.Y. and Hsu, L.C. (1989) Hepatitis B virus markers in Chinese twins. Anticancer Res., 9, 737-742.
7. Herndon, C.N. and Jennings, R.G. (1951) A twin-family study of susceptibility to poliomyelitis. Am. J. Hum. Genet., 3, 17-46.
8. Colhoun, H.M., McKeigue, P.M. and Davey Smith, G. (2003) Problems of reporting genetic associations with complex outcomes. Lancet, 361, 865-872.
9. Bryant, P.A., Venter, D., Robins-Brovcrne, R. and Curtis, N. (2004) Chips with everything: DNA microarrays in infectious diseases. Lancet Infect. Dis., 4, 100-111.
10. Reiling, N., Holscher, C., Fehrenbach, A., Kroger, S., Kirschning, C.J., Goyert, S. and Ehlers, S. (2002) Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol., 169, 3480-3484.
11. Lazzaro, B.P., Sceurman, B.K. and Clark, A.G. (2004) Genetic basis of natural variation in D. melanogaster antibacterial immunity. Science, 303, 1873-1876.
12. Wasserman, S.A. (2004) Nature's fortress against infection. Nat. Immunol., 5, 474-475.
13. Bellamy, R., Beyers, N., McAdam, KP., Ruwende, C., Gie, R., Samaai, P., Bester, D., Meyer, M., Corrah, T., Collin, M. et al. (2000) Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc. Natl Acad. Sci. USA, 97, 8005-8009.
14. Jepson, A., Sisay-Joof, F., Banya, W., Hassan-King, M., Frodsham, A., Bennett, S., Hill, A.V. and Whittle, H. (1997) Genetic linkage of mild malaria to the major histocompatibility complex in Gambian children: study of affected sibling pairs. Br. Med. J., 315, 96-97.
15. Marquet, S., Abel, L., Hillaire, D. and Dessein, A. (1999) Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome Sq31-q33. Eur. J. Hum. Genet., 7, 88-97.
16. Mira, M.T., Alcais, A., Van Thuc, N., Thai, V.H., Huong, N.T., Ba, N.N., Verner, A., Hudson, T.J., Abel, L. and Schurr, E. (2003) Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat. Genet., 33, 412-415.
17. Siddiqui, M.R., Meisner, S., Tosh, K., Balakrishnan, K., Ghei, S., Fisher, S.E., Golding, M., Shanker Narayan, N.P., Sitaraman, T., Sengupta, U. et al. (2001) A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat. Genet., 27, 439-441.
18. Tosh, K., Meisner, S., Siddiqui, M.R., Balakrishnan, K., Ghei, S., Golding, M., Sengupta, U., Pitchappan, R.M. and Hill, A.V. (2002) A region of chromosome 20 is linked to leprosy susceptibility in a South Indian population. J. Infect. Dis., 186, 1190-1193.
19. Bucheton, B., Abel, L., El-Safi, S., Kheir, M.M., Pavek, S., Lemainque, A. and Dessein, A.J. (2003) A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am. J. Hum. Genet., 73, 1052-1060.
20. Newport, M.J., Huxley, C.M., Huston, S., Hawrylowicz, C.M., Oostra, B.A., Williamson, R. and Levin, M. (1996) A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med., 335, 1941-1949.
21. Levin, M., Newport, M.J., D'Souza, S., Kalabalikis, P., Brown, LN., Lenicker, H.M., Agius, P.V., Davies, E.G., Thrasher, A., Klein, N. et al. (1995) Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet, 345, 79-83.
22. Butler, D., Maurice, J. and O'Brien, C. (1997) Time to put malaria control on the global agenda. Nature, 386, 535-536.
23. Allison, A.C. (1954) Protection afforded by sickle-cell trait against subtertian malareal infection. Br. Med. J., 4857, 290-294.
24. Hill, A.V., Allsopp, C.E., Kwiatkowski, D., Anstey, N.M., Twumasi, P., Rowe, P.A., Bennett, S., Brewster, D., McMichael, A.J. and Greenwood, B.M. (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature, 352, 595-600.
25. Hutagalung, R., Wilairatana, P., Looareesuwan, S., Brittenham, G.M., Aikawa, M. and Gordeuk, V.R. (1999) Influence of hemoglobin E trait on the severity of Falciparum malaria. J. Infect. Dis., 179, 283-286.
26. Chotivanich, K., Udomsangpetch, R., Pattanapanyasat, K., Chierakul, W., Simpson, J., Looareesuwan, S. and White, N. (2002) Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P. falciparum malaria. Blood, 100, 1172-1176.
27. Modiano, D., Luoni, G., Sirima, B.S., Simpore, J., Verra, F., Konate, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G.M. et al. (2001) Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature, 414, 305-308.
28. Flint, J., Hill, A.V., Bowden, D.K., Oppenheimer, S.J., Sill, P.R., Serjeantson, S.W., Bana-Koiri, J., Bhatia, K.. Alpers, M.P., Boyce, A.J. et al. (1986) High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature, 321, 744-750.
29. Rougemont, A., Quilici, M., Delmont, J. and Ardissone, J.P. (1980) Is the HpO phenomenon in tropical populations really genetic? Hum. Hered., 30, 201-203.
30. Hill, A.V., Whitehouse, D.B., Bowden, D.K., Hopkinson, D.A., Draper, C.C., Peto, T.E., Clegg, J.B. and Weatherall, D.J. (1987) Ahaptoglobinaemia in Melanesia: DNA and malarial antibody studies. Trans. R. Soc. Trop. Med. Hyg., 81, 573-577.
31. Boreham, P.F., Lenahan, J.K., Port, G.R. and McGregor, LA. (1981) Haptoglobin polymorphism and its relationship to malaria infections in The Gambia. Trans. R. Soc. Top. Med. Hyg., 75, 193-200.
32. Elagib, A.A., Kider, A.O., Akerstrom, B. and Elbashir, M.I. (1998) Association of the haptoglobin phenotype (1-1) with falciparum malaria in Sudan. Trans. R. Soc. Trop. Med. Hyg., 92, 309-311.
33. Quaye, I.K., Ekuban, F.A., Goka, B.Q., Adabayeri, V., Kurtzhals, J.A., Gyan, B., Ankrah, N.A., Hviid, L. and Akanmori, B.D. (2000) Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg., 94, 216-219.
34. Aucan, C., Walley, A.J., Greenwood, B.M. and Hill, A.V. (2002) Haptoglobin genotypes are not associated with resistance to severe malaria in The Gambia. Trans. R. Soc. Trop. Med. Hyg., 96, 327-328.
35. Tournamille, C., Colin, Y., Cartron, J.P. and Le Van Kim, C. (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10, 224-228.
36. Miller, L.H., Mason, S.J., Dvorak, J.A., McGinniss, M,H. and Rothman, LK. (1975) Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science, 189, 561-563.
37. Sabeti, P.C., Reich, D.E., Higgins, J.M., Levine, H.Z., Richter, D.J., Schaffner, S.F., Gabriel, S.B., Platko, J.V., Patterson, N.J., McDonald, G.J. et al. (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature, 419, 832-837.
38. Ruwende, C., Khoo, S.C., Snow, R.W., Yates, S.N., Kwiatkowski, D., Gupta, S., Warn, P., Allsopp, C.E., Gilbert, S.C., Peschu, N. et al. (1995) Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature, 376, 246-249.
39. Sabeti, P., Usen, S., Farhadian, S., Jallow, M., Doherty, T., Newport, M., Pinder, M., Ward, R. and Kwiatkowski, D. (2002) CD40L association with protection from severe malaria. Genes Immun., 3 286-291.
40. McGuire, W., Hill, A.V., Allsopp, C.E., Greenwood, B.M. and Kwiatkowski, D. (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature, 371 508-510.
41. McGuire, W., Knight, J.C., Hill, A.V., Allsopp, C.E., Greenwood, B.M. and Kwiatkowski, D. (1999) Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis., 179, 287-290.
42. Knight, J.C., Udalova, I., Hill, A.V., Greenwood, B.M., Peshu, N., Marsh, K. and Kwiatkowski, D. (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet., 22, 145-150.
43. Cooke, G.S., Aucan, C., Walley, A.J., Segal, S., Greenwood, B.M., Kwiatkowski, D.P. and Hill, A. V. (2003) Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am. J. Trop. Med. Hyg., 69, 565-568.
44. Aucan, C., Walley, A.J., Hennig, B.J., Fitness, J., Frodsham, A., Zhang, L., Kwiatkowski, D. and Hill, A.V. (2003) Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in The Gambia. Genes Immun., 4, 275-282.
45. Koch, O., Awomoyi, A., Usen, S., Jallow, M., Richardson, A., Hull, J., Pinder, M., Newport, M. and Kwiatkowski, D. (2002) IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J. Infect. Dis., 185, 1684-1687.
46. Modiano, D., Petrarca, V., Sirima, B.S., Nebie, L., Diallo, D., Esposito, F. and Coluzzi, M. (1996) Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc. Natl Acad. Sci. USA, 93, 13206-13211.
47. Luoni, G., Verra, F., Arca, B., Sirima, B.S., Troye-Blomberg, M., Coluzzi, M., Kwiatkowski, D. and Modiano, D. (2001) Antimalarial antibody levels and ILA polymorphism in the Fulani of West Africa. Genes Immun., 2, 411-414.
48. Carrington, M., Nelson, G.W., Martin, M.P., Kissner, T., Vlahov, D., Goedert, J.J., Kaslow, R., Buchbinder, S., Hoots, K. and O'Brien, S.J. (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science, 283, 1748-1752.
49. McNeil, A.J., Yap, P.L., Gore, S.M., Brettle, R.P., McColl, M., Wyld, R., Davidson, S., Weightman, R., Richardson, A.M. and Robertson, J.R. (1996) Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. Quad. J. Med., 89, 177-185.
50. Migueles, S.A., Sabbaghian, M.S., Shupert, W.L., Bettinotti, M.P., Marincola, F.M., Martino, L., Hallahan, C.W., Selig, S.M., Schwartz, D., Sullivan, J. et al. (2000) HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl Acad. Sci. USA, 97, 2709-2714.
51. Hill, A.V., Yates, S.N., Allsopp, C.E., Gupta, S., Gilbert, S.C., Lalvani, A., Aidoo, M., Davenport, M. and Plebanski, M. (1994) Human leukocyte antigens and natural selection by malaria. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 346, 379-385.
52. Ravikumar, M., Dheenadhayalan, V., Rajaram, K., Lakshmi, S.S., Kumaran, P.P., Paramasivan, C.N., Balakrishnan, K. and Pitchappan, R.M. (1999) Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in South India. Tuber. Lung. Dis., 79, 309-317.
53. Shaw, M.A., Donaldson, L.J., Collins, A., Peacock, C.S., Lins-Lainson, Z., Shaw, J.J., Ramos, F., Silveira, F. and Blackwell, J.M. (2001) Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun., 2, 196-204.
54. Singh, S.P., Mehra, N.K., Dingley, H.B., Pande, J.N. and Vaidya, M.C. (1983) HLA-DR associated genetic control of pulmonary tuberculosis in north India. Indian J. Chest Dis. Allied Sci., 25, 252-258.
55. de Vries, R.R., Fat, R.F., Nijenhuis, L.E. and van Rood, J.J. (1976) HLA-linked genetic control of host response to Mycobacterium leprae. Lancet, 2, 1328-1330.
56. Thursz, M.R., Kwiatkowski, D., Allsopp, C.E., Greenwood, B.M., Thomas, H.C. and Hill, A.V. (1995) Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med., 332, 1065-1069.
57. Almarri, A. and Batchelor, J.R. (1994) HLA and hepatitis B infection (see comments). Lancet, 344, 1194-1195.
58. Zavaglia, C., Bortolon, C., Ferrioli, G., Rho, A., Mondazzi, L., Bottelli, R., Ghessi, A., Gelosa, F., Iamoni, G. and Ideo, G. (1996) HLA typing in chronic type B, D and C hepatitis. J. Hepatol., 24 658-665.
59. Gilbert, S.C., Plebanski, M., Gupta, S., Morris, J., Cox, M., Aidoo, M., Kwiatkowski, D., Greenwood, B.M., Whittle, H.C. and Hill, A.V. (1998) Association of malaria parasite population structure, HLA, and immunological antagonism. Science, 279, 1173-1177.
60. Young, K., Frodsham, A., Doumbo, O.K., Gupta, S., Dole, A., Hu, J., Robson, K.J.H., Crisanti, A., Gilbert, S.C. and Hill, A.V. (2004) Inverse associations of HLA and malaria parasite type in two West African populations. Infect. Immun., in press.
61. Fine, P.E. (1981) Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective. Int. J. Lepr. Other Mycobact. Dis., 49, 437-454.
62. Abel, L. and Demenais, F. (1988) Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean Island: Desirade island. Am. J. Hum. Genet., 42, 256-266.
63. Mira, M.T., Alcais, A., Nguyen, V.T., Moraes, M.O., Di Flumeri, C., Vu, H.T., Mai, C.P., Nguyen, T.H., Nguyen, N.B., Pham, X.K. et al. (2004) Susceptibility to leprosy is associated with PARK2 and PACRG. Nature, 427, 636-640.
64. West, A.B., Lockhart, P.J., O'Farell, C. and Farrer, M,J. (2003) Identification of a novel gene linked to Parkin via a bi-directional promoter. J. Mol. Biol., 326, 11-19.
65. West, A., Periquet, M., Lincoln, S., Lucking, C.B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lehmann, E., Deleuze, J.F. et al. (2002) Complex relationship between Parkin mutations and Parkinson disease. Am. J. Med. Genet., 114, 584-591.
66. Imai, Y., Soda, M., Murakami, T., Shoji, M., Abe, K. and Takahashi, R. (2003) A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death. J. Biol. Chem., 278, 51901-51910.
67. Cervino, A.C., Lakiss, S., Sow, O., Bellamy, R., Beyers, N., Hoal-van Helden, E., van Helden, P., McAdam, K.P. and Hill, A.V. (2002) Fine mapping of a putative-taberculosis-susceptibility locus on chromosome 15q11-13 in African families. Hum. Mol. Genet., 11 1599-1603.
68. Campbell, S.J., Sabeti, P., Fielding, K., Sillah, J., Bah, B., Gustafson, P., Manneh, K., Lisse, L, Sirugo, G., Bellamy, R, et al. (2003) Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa. Immunogenetics, 55, 502-507.
69. Blackwell, J.M., Black, G.F., Peacock, C.S., Miller, E.N., Sibthorpe, D., Gnananandha, D., Shaw, J.J., Silveira, F., Lins-Lainson, Z., Ramos, F. et al. (1997) Immunogenetics of leishmanial and mycobacterial infections: the Belem family study. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 352, 1331-1345.
70. Miller, E.N., Jamieson, S.E., Joberty, C., Fakiola, M., Hudson, D., Peacock, C.S., Cordell, H.J., Shaw, M.A., Lins-Lainson, Z., Shaw, J.J. et al. (2004) Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun., 5 63-67.
71. Jamieson, S.E., Miller, E.N., Black, G.F., Peacock, C.S., Cordell, H.J., Howson, J.M., Shaw, M.A., Burgner, D., Xu, W., Lins-Lainson, Z. et al. (2004) Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun., 5, 46-57.
72. Vidal, S.M., Malo, D., Vogan, K., Skamene, E. and Gros, P. (1993) Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell, 73, 469-485.
73. Malo, D., Vogan, K., Vidal, S., Hu, J., Cellier, M., Schurr, E., Fuks, A., Bumstead, N., Morgan, K. and Gros, P. (1994) Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics, 23, 51-61.
74. Bellamy, R. (1999) The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. Microbes Infect., 1, 23-27.
75. Awomoyi, A.A., Marchant, A., Howson, J.M., McAdam, K.P., Blackwell, J.M. and Newport, M.J. (2002) Interleukin-10, polymorphism in SLC11A1 (formerly NRAMPI), and susceptibility to tuberculosis. J. Infect. Dis., 186, 1808-1814.
76. Cervino, A.C., Lakiss, S., Sow, O. and Hill, A.V. (2000) Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry. Ann. Hum. Genet., 64, 507-512.
77. Ryu, S., Park, Y.K., Bai, G.H., Kim, S.J., Park, S.N. and Kang, S. (2000) 3′UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. Int. J. Tuberc. Lung. Dis., 4, 577-580.
78. Gao, P.S., Fujishima, S., Mao, X.Q., Remus, N., Kanda, M., Enomoto, T., Dake, Y., Bottini, N., Tabuchi, M., Hasegawa, N. et al. (2000) Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin. Genet. 58, 74-76.
79. Ma, X., Dou, S., Wright, J.A., Reich, R.A., Teeter, L.D., El Sahly, H.M., Awe, R.J., Musser, J.M. and Graviss, E.A. (2002) 5′ dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston. Texas. Int. J. Tuberc. Lung. Dis., 6, 818-823.
80. Liaw, Y.S., Tsai-Wu, J.J., Wu, C.H., Hung, C.C., Lee, C.N., Yang, P.C., Luh, K.T. and Kuo, S.H. (2002) Variations in the NRAMP1 gene and susceptibility of tuberculosis in Taiwanese. Int. J. Tuberc. Lung. Dis., 6, 454-460.
81. Soborg, G., Andersen, A.B., Madsen, H.O., Kok-Jensen, A., Skinhoj, P. and Garred, P. (2002) Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis. J. Infect. Dis., 186, 517-521.
82. El Baghdadi, J., Remus, N., Benslimane, A., El Annaz, H., Chentoufi, M., Abel, L. and Schurr, E. (2003) Vaniants of the human NRAMP1 gene and susceptibility to tuberculosis in Morocco. Int. J. Tuberc. Lung. Dis., 7, 599-602.
83. Abel, L., Vu, D.L., Oberti, J., Nguyen, V.T., Van, V.C., Guilloud-Bataille, M., Schurr, E. and Lagrange, P.H. (1995) Complex segregation analysis of leprosy in southern Vietnam. Genet. Epidemiol. 12, 63-82.
84. Shaw, M.A., Atkinson, S., Dockrell, H., Hussain, R., Lins-Lainson, Z., Shaw, J., Ramos, F., Silveira, F., Mehdi, S.Q., Kaukab, F. et al. (1993) An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy. Ann. Hum. Genet., 57 (Pt 4), 251-271.
85. Roy, S., Frodsham, A., Saha, B., Hazra, S.K., Mascie-Taylor, C.G. and Hill, A.V. (1999) Association of vitamin D receptor genotype with leprosy type. J. Infect. Dis., 179, 187-191.
86. Meisner, S.J., Mucklow, S., Warner, G., Sow, S.O., Lienhardt, C. and Hill, A.V. (2001) Association of NRAMP1 polymorphism with leprosy type but not susceptibility to leprosy per se in west Africans. Am. J. Trop. Med. Hyg., 65, 733-735.
87. D'Ambrosio, D., Cippitelli, M., Cocciolo, M.G., Mazzeo, D., Di Lucia, P., Lang, R., Sinigaglia, F. and Panina-Bordignon, P. (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest., 101, 252-262.
88. Cippitelli, M. and Santoni, A. (1998) Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur. J. Immunol., 28, 3017-3030.
89. Bellamy, R., Ruwende, C., Corrah, T., McAdam, K.P., Thursz, M., Whittle, H.C. and Hill, A.V. (1999) Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis., 179, 721-724.
90. Bornman, L., Campbell, S.J., Fielding, K., Bah, B., Sillah, J., Gustafson, P., Manneh, K., Lisse, L, Allen, A., Sirugo, G. et al. (2004) Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J. Infect. Dis., in press.
91. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M. and Hoffinann, J.A. (1996) The dorsoventral regulatory gene cassette spatzle/Tol/cactus controls the potent antifungal response in Drosophila adults. Cell, 86, 973-983.
92. Poltorak, A., Smirnova, L, He, X., Liu, M.Y., Van Huffel, C., McNally, O., Birdwell, D., Alejos, E., Silva, M., Du, X. et al. (1998) Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis., 24, 340-355.
93. Poltorak, A., He, X., Smirnova, I, Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C. et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 282, 2085-2088.
94. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. and Akira, S. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol., 162, 3749-3752.
95. Heldwein, K.A. and Fenton, M.J. (2002) The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect., 4, 937-944.
96. Ogus, A.C., Yoldas, B., Ozdemir, T., Uguz, A., Olcen, S., Keser, I., Coskun, M., Cilli, A. and Yegin, O. (2004) The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J., 23, 219-223.
97. Ben-Ali, M., Barbouche, M.R., Bousnina, S., Chabbou, A. and Dellagi, K. (2004) Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol., 11, 625-626.
98. Kang, T.J. and Chae, G.T. (2001) Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol., 31, 53-58.
99. Yim, J.J., Ding, L., Schaffer, A.A., Park, G.Y., Shim, Y.S. and Holland, S.M. (2004) A microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene: functional implications and racial differences. FEMS Immunol. Med. Microbiol., 40, 163-169.
100. Cooke, G.S., Segal, S. and Hill, A.V. (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med., 347, 1978-1980; author reply 1978-1980.
101. Shim, T.S., Turner, O.C. and Orme, LM. (2003) Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection. Tuberculosis (Edinb.), 83, 367-371.
102. Ma, X., Reich, R.A., Wright, J.A., Tooker, H.R., Teeter, L.D., Musser, J.M. and Graviss, E.A. (2003) Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. J. Infect. Dis., 188, 349-355.
103. Rossouw, M., Nel, H.J., Cooke, G.S., van Helden, P.D. and Hoal, E.G. (2003) Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet, 361 1871-1872.
104. Garred P., Madsen, H.O., Balslev, U., Hofmann, B., Pedersen, C., Gerstoft, J. and Svejgaard, A. (1997) Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet, 349, 236-240.
105. Hoal-Van Helden, E.G., Epstein, J., Victor, T.C., Hon, D., Lewis, L.A., Beyers, N., Zurakowski, D., Ezekowitz, A.B. and Van Helden, P.D. (1999) Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr. Res., 45, 459-464.
106. Soborg, C., Madsen, H.O., Andersen, A.B., Lillebaek, T., Kok-Jensen, A. and Garred, P. (2003) Mannose-binding lectin polymorphisms in clinical tuberculosis. J. Infect. Dis., 188, 777-782.
107. Cooke, G.S., Campbell, S.J., Fielding, K., Sillah, J., Manneh, K., Sirugo, G., Bennett, S., McAdam, K.P., Lienhardt, C. and Hill, A.V. (2004) Interleukin-8 polymorphism is not associated with pulmonary tuberculosis in the gambia. J. Infect. Dis., 189, 1545-1546; author reply 1546.
108. Bellamy, R., Ruwende, C., McAdam, K.P., Thursz, M., Sumiya, M., Summerfield, J., Gilbert, S.C., Corrah, T., Kwiatkowski, D., Whittle, H.C. et al. (1998) Mannose-binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. Quat. J. Med., 91, 13-18.
109. Lio, D., Marino, V., Serauto, A., Gioia, V., Scola, L., Crivello, A., Forte, G.L, Colonna-Romano, G., Candore, G. and Caruso, C. (2002) Genotype frequencies of the +874T → A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis. Eur. J. Immunogenet. 29, 371-374.
110. Fowke, K.R., Nagelkerke, N.J., Kimani, J., Simonsen, J.N., Anzala, A.O., Bwayo, J.J., MacDonald, K.S., Ngugi, E.N. and Plummer, F.A. (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet, 348, 1347-1351.
111. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R., Goedert, J.J., Buchbinder, S.P., Vittinghoff, E., Gomperts, E. et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science, 273, 1856-1862.
112. Huang, Y., Paxton, W.A., Wolinsky, S.M., Neumann, A.U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K. et al. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med., 2, 1240-1243.
113. Smith, M.W., Carrington, M., Winkler, C., Lomb, D., Dean, M., Huttley, G. and O'Brien, S.J. (1997) CCR2 chemokine receptor and AIDS progression. Nat. Med., 3, 1052-1053.
114. An, P., Nelson, G.W., Wang, L., Donfield, S., Goedert, J.J., Phair, J., Vlahov, D., Buchbinder, S., Farrar, W.L., Modi, W. et al. (2002) Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc. Natl Acad. Sci. USA, 99, 10002-10007.
115. Liu, X.L., Wang, F.S., Jin, L., Liu, M.X. and Xu, D.Z. (2003) Preliminary study on the association of chemokine RANTES gene polymorphisms with HIV-1 infection in Chinese Han population. Zhonghua Liu Xing Bing Xue Za Zhi, 24, 971-975.
116. Mummidi, S., Ahuja, S.S., Gonzalez, E., Anderson, S.A., Santiago, E.N., Stephan, K.T., Craig, F.E., O'Connell, P., Tryon, V., Clark, R.A. et al. (1998) Genealogy of the CCRS locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat. Med., 4, 786-793.
117. Winkler, C., Modi, W., Smith, M.W., Nelson, G.W., Wu, X., Carrington, M., Dean, M., Honjo, T., Tashiro, K., Yabe, D. et al. (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE study, hemophilia growth and development study (HGDS), multicenter AIDS cohort study (MACS), multicenter hemophilia cohort study (MHCS), San Francisco city cohort (SFCC). Science, 279, 389-393.
118. Nakayama, E.E., Hoshino, Y., Xin, X., Liu, H., Goto, M., Watanabe, N., Taguchi, H., Hitani, A., Kawana-Tachikawa, A., Fukushima, M. et al. (2000) Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype. J. Virol., 74, 5452-5459.
119. Shin, H.D., Winkler, C., Stephens, J.C., Bream, J., Young, H., Goedert, J.J., O'Brien, T.R., Vlahov, D., Buch binder, S., Giorgi, J. et al. (2000) Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc. Natl Acad. Sci. USA, 97, 14467-14472.
120. Smolnikova, M.V. and Konenkov, V.I. (2002) Association of IL2, TNFA, IL4 and IL10 promoter gene polymorphisms with the rate of progression ofthe HIV infection. Russ. J. Immunol., 7, 349-356.
121. Marquet, S., Sanchez, F.O., Arias, M., Rodriguez, J., Paris, S.C., Skamene, E., Schurr, E. and Garcia, L.F. (1999) Variants of the human NRAMP1 gene and altered human immunodeficiency virus infection susceptibility. J. Infect. Dis., 180, 1521-1525.
122. Donninger, H., Cashmore, T.J., Scriba, T., Petersen, D.C., Janse van Rensburg, E. and Hayes, V.M. (2004) Functional analysis of novel SLC11 A1 (NRAMPI) promoter variants in susceptibility to HIV-1. J. Med. Genet., 41, e49.
123. Bafica, A., Scanga, C.A., Schito, M., Chaussabel, D. and Sher, A. (2004) Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J. Immunol., 172, 7229-7234.
124. Hohler, T., Kruger, A., Gerken, G., Schneider, P.M., Meyer zum Buschenefelde, K.H. and Rittner, C. (1998) A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin. Exp. Immunol., 111, 579-582.
125. Thomas, H.C., Foster, G.R., Sumiya, M., McIntosh, D., Jack, D.L., Turner, M.W. and Summerfield, J.A. (1996) Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection (see comments). Lancet, 348, 1417-1419.
126. Woitas, R.P., Ahlenstiel, G., Iwan, A., Rockstroh, J.K., Brackmann, H.H., Kupfer, B., Matz, B., Offergeld, R., Sauerbruch, T. and Spengler, U. (2002) Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology, 122, 1721-1728.
127. Promrat, K., McDermott, D.H., Gonzalez, C.M., Kleiner, D.E., Koziol, D.E., Lessie, M., Merrell, M., Soza, A., Heller, T., Ghany, M. et al. (2003) Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology, 124, 352-360.
128. Mangia, A., Santoro, R., D'Agruma, L. and Andriulli, A. (2003) HCV chronic infection and CCRS-delta32/delta32. Gastroenterology, 124, 868-869; author reply 869-870.
129. Mascheretti, S., Hinrichsen, H., Ross, S., Buggisch, P., Hampe, J., Foelsch, U.R. and Schreiber, S. (2004) Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients. Clin. Exp. Immunol., 136, 328-333.
130. Hellier, S., Frodsham, A.J., Hennig, B.J., Klenerman, P., Knapp, S., Ramaley, P., Satsangi, J., Wright, M., Zhang, L., Thomas, B.C. et al. (2003) Association of genetic variants of the chemokine receptor CCRS and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology, 38, 1468-1476.
131. Knapp, S., Yee, L.J., Frodsham, A.J., Hennig, B.J., Hellier, S., Zhang, L., Wright, M., Chiaramonte, M., Graves, M., Thomas, B.C. et al. (2003) Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun., 4, 411-419.
132. Edwards-Smith, C.J., Jonsson, JR., Purdie, D.M., Bansal, A., Shorthouse, C. and Powell, E.E. (1999) Interleukin-10-promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology, 30, 526-530.
133. Yee, L.J., Tang, J., Gibson, A.W., Kimberly, R., Van Leeuwen, D.J. and Kaslow, R.A. (2001) Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology, 33, 708-712.
134. Knapp, S., Hennig, B.J., Frodsham, A.J., Zhang, L., Hellier, S., Wright, M., Goldin, R., Hill, A.V., Thomas, H.C. and Thursz, M.R. (2003) Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics, 55, 362-369.
135. The International HapMap Project. (2003) Nature, 426 789-796.
136. Bentley, D.R. (2000) The human genome project - an overview. Med. Res. Rev., 20, 189-196.